LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 308 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $82,000 | +60.8% | 656 | +75.9% | 0.01% | +20.0% |
Q4 2018 | $51,000 | -51.4% | 373 | -2.4% | 0.01% | -44.4% |
Q3 2018 | $105,000 | +34.6% | 382 | +1.6% | 0.01% | +28.6% |
Q2 2018 | $78,000 | +50.0% | 376 | +19.7% | 0.01% | +40.0% |
Q1 2018 | $52,000 | +48.6% | 314 | +21.2% | 0.01% | +66.7% |
Q4 2017 | $35,000 | +29.6% | 259 | +30.8% | 0.00% | 0.0% |
Q3 2017 | $27,000 | +440.0% | 198 | +340.0% | 0.00% | +200.0% |
Q2 2017 | $5,000 | – | 45 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 1,249,766 | $58,726,504,000 | 11.17% |
BVF INC/IL | 1,108,763 | $52,101,000 | 10.82% |
GROW Partners, LLC | 132,500 | $6,226,000 | 5.58% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 936,825 | $44,021,000 | 2.73% |
First Light Asset Management, LLC | 76,366 | $3,588,000 | 2.45% |
Healthcare Value Capital, LLC | 50,000 | $2,350,000 | 2.27% |
OBERWEIS ASSET MANAGEMENT INC/ | 168,337 | $7,910,000 | 2.17% |
RK Capital | 174,283 | $8,190,000 | 1.67% |
Nichols Asset Management LLC | 133,368 | $6,267,000 | 1.30% |
ASHFORD CAPITAL MANAGEMENT INC | 108,289 | $5,089,000 | 1.09% |